Human regulatory T cells in allogeneic stem cell transplantation

Blood

Volumn 118, Issue 13, 2011, Pages

  Ukena, Sya N ^a   Velaga, Sarvari ^a   Geffers, Robert ^b   Grosse, Jens ^a   Baron, Udo ^c   Buchholz, Stefanie ^a   Stadler, Michael ^a   Bruder, Dunja ^b   Ganser, Arnold ^a   Franzke, Anke ^a  

^a HANNOVER MEDICAL SCHOOL   (Germany)

^b HELMHOLTZ CENTRE FOR INFECTION RESEARCH   (Germany)

^c EPIONTIS GMBH   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

CHEMOKINE RECEPTOR CCR5; CHEMOKINE RECEPTOR CXCR3; GRANZYME A; TRANSCRIPTOME;

ADULT; AGED; ALLOGENEIC STEM CELL TRANSPLANTATION; ARTICLE; CD4+ CD25+ T LYMPHOCYTE; FEMALE; GENOME; GRAFT VERSUS HOST REACTION; HUMAN; HUMAN CELL; MALE; PRIORITY JOURNAL; PROTEIN EXPRESSION; REGULATORY T LYMPHOCYTE; TRANSCRIPTION REGULATION;

EID: 80053352107     PISSN: 00064971     EISSN: 15280020     Source Type: Journal    
DOI: 10.1182/blood-2011-05-352708     Document Type: Article

References (44)

1. Gooley TA, Chien JW, Pergam SA, et al. Reduced mortality after allogeneic hematopoieticcell transplantation. N Engl J Med. 2010;363(22):2091-2101.
2. Sakaguchi S. Naturally arising Foxp3-expressing CD25(+) CD4(+) regulatory T cells in immunological tolerance to self and non-self. Nat Immunol. 2005;6(4):345-352. (Pubitemid 41716771)
3. Anderson BE, McNiff JM, Matte C, et al. Recipient CD4(+) T cells that survive irradiation regulate chronic graft-versus-host disease. Blood. 2004;104(5):1565-1573. (Pubitemid 39166539)
4. Cohen JL, Trenado A, Vasey D, Klatzmann D, Salomon BL. CD4(+)CD25(+) immunoregulatory T cells: new therapeutics for graft-versus-host disease. J Exp Med. 2002;196(3):401-406. (Pubitemid 34875668)
5. Hoffmann P, Ermann J, Edinger M, Fathman CG, Strober S. Donor-type CD4(+)CD25(+) regulatory T cells suppress lethal acute graft-versushost disease after allogeneic bone marrow transplantation. J Exp Med. 2002;196(3):389-399. (Pubitemid 34875667)
6. Taylor PA, Lees CJ, Blazar BR. The infusion of ex vivo activated and expanded CD4(+)CD25(+) immune regulatory cells inhibits graft-versus-host disease lethality. Blood. 2002;99(10):3493-3499. (Pubitemid 34534513)
7. Sakaguchi S, Miyara M, Costantino CM, Hafler DA. FOXP3(+) regulatory T cells in the human immune system. Nat Rev Immunol. 2010;10(7):490-500.
8. Bollyky PL, Lord JD, Masewicz SA, et al. Cutting edge: high molecular weight hyaluronan promotes the suppressive effects of CD4(+)CD25(+) regulatory T cells. J Immunol. 2007;179(2):744-747.
9. Firan M, Dhillon S, Estess P, Siegelman MH. Suppressor activity and potency among regulatory T cells is discriminated by functionally active CD44. Blood. 2006;107(2):619-627. (Pubitemid 43076386)
10. Liu T, Soong L, Liu G, Konig R, Chopra AK. CD44 expression positively correlates with Foxp3 expression and suppressive function of CD4(+) T-reg cells. Biol Direct. 2009;4:40.
11. Shevach EM. Mechanisms of Foxp3(+) T regulatory cell-mediated suppression. Immunity. 2009;30(5):636-645.
12. Rabinovich GA, Baum LG, Tinari N, et al. Galectins and their ligands: amplifiers, silencers or tuners of the inflammatory response? Trends Immunol. 2002;23(6):313-320. (Pubitemid 34628775)
13. Grossman WJ, Verbsky JW, Tollefsen BL, et al. Differential expression of granzymes A and B in human cytotoxic lymphocyte subsets and T regulatory cells. Blood. 2004;104(9):2840-2848. (Pubitemid 39434970)
14. Huehn J, Siegmund K, Lehmann JCU, et al. Developmental stage, phenotype, and migration distinguish naive- and effector/memory-like CD4(+) regulatory T cells. J Exp Med. 2004;199(3):303-313. (Pubitemid 38252043)
15. Sakaguchi S, Sakaguchi N, Asano M, Itoh M, Toda M. Immunological self-tolerance maintained by activated T-cells expressing Il-2 receptor alpha-chains (Cd25): breakdown of a single mechanism of self-tolerance causes various autoimmune-diseases. J Immunol. 1995;155(3):1151-1164.
16. Ichiba T, Teshima T, Kuick R, et al. Early changes in gene expression profiles of hepatic GVHD uncovered by oligonucleotide microarrays. Blood. 2003;102(2):763-771. (Pubitemid 36842004)
17. Jaksch M, Remberger M, Mattsson J. Increased gene expression of chemokine receptors is correlated with acute graft-versus-host disease after allogeneic stem cell transplantation. Biol Blood Marrow Transplant. 2005;11(4):280-287. (Pubitemid 40450755)
18. Varona R, Cadenas V, Gomez L, Martinez AC, Marquez G. CCR6 regulates CD4(+) T-cell-mediated acute graft-versus-host disease responses. Blood. 2005;106(1):18-26. (Pubitemid 40967169)
19. Welniak LA, Wang Z, Sun K, et al. An absence of CCR5 on donor cells results in acceleration of acute graft-vs-host disease. Exp Hematol. 2004;32(3):318-324. (Pubitemid 38328538)
20. Duffner U, Lu B, Hildebrandt GC, et al. Role of CXCR3-induced donor T-cell migration in acute GVHD. Exp Hematol. 2003;31(10):897-902. (Pubitemid 37211374)
21. Wysocki CA, Burkett SB, Panoskaltsis-Mortari A, et al. Differential roles for CCR5 expression on donor T cells during graft-versus-host disease based on pretransplant conditioning. J Immunol. 2004;173(2):845-854. (Pubitemid 38930812)
22. Brunstein CG, Miller JS, Cao Q, et al. Infusion of ex vivo expanded T regulatory cells in adults transplanted with umbilical cord blood: safety profile and detection kinetics. Blood. 2011;117(3):1061-1070.
23. di Ianni M, Falzetti F, Carotti A, et al. Tregs prevent GVHD and promote immune reconstitution in HLA-haploidentical transplantation. Blood. 2011;117(14):3921-3928.
24. Przepiorka D, Weisdorf D, Martin P, et al. Consensus Conference on Acute Gvhd Grading. Bone Marrow Transplant. 1995;15(6):825-828.
25. Ukena SN, Westendorf AM, Hansen W, et al. The host response to the probiotic Escherichia coli strain Nissle 1917: specific up-regulation of the proinflammatory chemokine MCP-1. BMC Med Genet. 2005;13(6):43.
26. Ukena SN, Singh A, Dringenberg U, et al. Probiotic Escherichia coli Nissle 1917 inhibits leaky gut by enhancing mucosal integrity. PLoS One. 2007 12;2(12):e1308.
27. Vorwerk S, Ganter K, Cheng Y, et al. Microfluidic-based enzymatic on-chip labeling of miRNAs. N Biotechnol. 2008;25(2):142-149.
28. Wieczorek G, Asemissen A, Model F, et al. Quantitative DNA methylation analysis of FOXP3 as a new method for counting regulatory T cells in peripheral blood and solid tissue. Cancer Res. 2009;69(2):599-608.
29. Mielke S, Rezvani K, Savani BN, et al. Reconstitution of FOXP3(+) regulatory T cells (T-regs) after CD25-depleted allotransplantion in elderly patients and association with acute graft-versus-host disease. Blood. 2007;110(5):1689-1697. (Pubitemid 47443988)
30. Rezvani K, Mielke S, Ahmadzadeh M, et al. High donor FOXP3-positive regulatory T-cell (T-reg) content is associated with a low risk of GVHD following HLA-matched allogeneic SCT. Blood. 2006;108(4):1291-1297. (Pubitemid 44232027)
31. Zorn E, Kim HT, Lee SJ, et al. Reduced frequency of FOXP3(+) CD4(+)CD25(+) regulatory T cells in patients with chronic graft-versus-host disease. Blood. 2005;106(8):2903-2911. (Pubitemid 41510772)
32. Rieger K, Loddenkemper C, Maul J, et al. Mucosal Foxp3(+) regulatory T cells are numerically deficient in acute and chronic GVHD. Blood. 2006;107(4):1717-1723. (Pubitemid 43242414)
33. Ermann J, Hoffmann P, Edinger M, et al. Only the CD62L(+) subpopulation of CD4(+)CD25(+) regulatory T cells protects from lethal acute GVHD. Blood. 2005;105(5):2220-2226. (Pubitemid 40731816)
34. Taylor PA, Panoskaltsis-Mortari A, Swedin JM, et al. L-Selectin(hi) but not the L-selectin(lo) CD4(+)25(+) T-regulatory cells are potent inhibitors of GVHD and BM graft rejection. Blood. 2004;104(12):3804-3812. (Pubitemid 39564461)
35. Wysocki CA, Jiang Q, Panoskaltsis-Mortari A, et al. Critical role for CCR5 in the function of donor CD4(+)CD25(+) regulatory T cells during acute graft-versus-host disease. Blood. 2005;106(9):3300-3307. (Pubitemid 41565933)
36. Takahashi N, Sato N, Takahashi S, Tojo A. Gene-expression profiles of peripheral blood mononuclear cell subpopulations in acute graft-vs-host disease following cord blood transplantation. Exp Hematol. 2008;36(12):1760-1770.
37. Hasegawa H, Inoue A, Kohno M, et al. Therapeutic effect of CXCR3-expressing regulatory T cells on liver, lung and intestinal damages in a murine acute GVHD model. Gene Ther. 2008;15(3):171-182. (Pubitemid 351175219)
38. Huehn J, Polansky JK, Hamann A. Epigenetic control of FOXP3 expression: the key to a stable regulatory T-cell lineage? Nat Rev Immunol. 2009;9(2):83-89.
39. Oh SJ, Cho SB, Park SH, et al. Cell cycle and immune-related processes are significantly altered in chronic GVHD. Bone Marrow Transplant. 2008;41(12):1047-1057. (Pubitemid 352042397)
40. Cai SF, Cao XF, Hassan A, Fehniger TA, Ley TJ. Granzyme B is not required for regulatory T cell-mediated suppression of graft-versus-host disease. Blood. 2010;115(9):1669-1677.
41. Hirst CE, Buzza MS, Bird CH, et al. The intracellular granzyme B inhibitor, proteinase inhibitor 9, is up-regulated during accessory cell maturation and effector cell degranulation, and its overexpression enhances CTL potency. J Immunol. 2003;170(2):805-815. (Pubitemid 36070532)
42. Perillo NL, Pace KE, Seilhamer JJ, Baum LG. Apoptosis of T-cells mediated by galectin-1. Nature. 1995;378(6558):736-739.
43. Baum LG, Blackall DP, Arias-Magallano S, et al. Amelioration of graft versus host disease by galectin-1. Clin Immunol. 2003;109(3):295-307. (Pubitemid 38091450)
44. Schmid C, Schleuning M, Ledderose G, Tischer J, Kolb HJ. Sequential regimen of chemotherapy, reduced- intensity conditioning for allogeneic stem-cell transplantation, and prophylactic donor lymphocyte transfusion in high-risk acute myeloid leukemia and myelodysplastic syndrome. J Clin Oncol. 2005;23(24):5675-5687.